Of interest, a recent study attempting to correlate Ki-67 proliferative index with Oncotype Dx recurrence score found no correlation between these two parameters in a cohort of ER+, HER2− patients with early breast cancer [9]. This evidence concerns the gene ESR1 and breast cancer.